je.st
news
Tag: combination
Drugmakers Pfizer, Allergan considering a combination: WSJ
2015-10-29 08:31:31| Biotech - Topix.net
REUTERS: Drugmakers Pfizer Inc and Allergan Plc are considering combining in what could be the biggest merger in the healthcare industry in already busy year, the Wall Street Journal said on Wednesday. The process is in its early stages, and may not yield an agreement, while other details of the talks are unclear, the report said.
Tags: combination
pfizer
wsj
allergan
MacroGenics and Merck to Collaborate on Immuno-Oncology Study Evaluating Margetuximab in Combination with KEYTRUDA (pembrolizumab) for Advanced Gastric Cancer
2015-10-22 13:30:46| Merck.com - Product News
Dateline City: ROCKVILLE, Md. and KENILWORTH, N.J. Clinical trial to evaluate MacroGenics' Fc-optimized anti-HER2 antibody with Merck's anti-PD-1 therapy in patients with advanced HER2-positive gastric cancer ROCKVILLE, Md.and KENILWORTH, N.J. Language: English read more
Tags: advanced
study
combination
cancer
Atlas Copco Receives Class 1 Certification for UD+ QDT Filter Combination
2015-10-16 12:31:14| Industrial Newsroom - All News for Today
Atlas Copco Airpower confirms its leadership in filtration through certifications and significant energy savings. ROCK HILL, S.C. - Atlas Copco Airpower is one of the first players in the compressed air filtration industry to receive ISO 8573-1:2010 class 1 certification for its UD+ QDT filter train. Atlas Copco's...
Tags: class
combination
filter
certification
Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda (pembrolizumab) as First-line Treatment for Advanced Melanoma
2015-10-13 13:30:03| Merck.com - Product News
Dateline City: WILMINGTON, Del. and KENILWORTH, N.J. Pivotal study to evaluate Incytes IDO1 inhibitor in combination with Mercks anti-PD-1 therapy in patients with advanced or metastatic melanoma WILMINGTON, Del. and KENILWORTH, N.J. -- Incyte Corporation (Nasdaq: INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the expansion of the companies ongoing clinical collaboration to include a Phase 3 study evaluating the combination of epacadostat, Incytes investigational selective IDO1 inhibitor, with Keytruda (pembrolizumab), Mercks anti-PD-1 therapy, as first-line treatment for patients with advanced or metastatic melanoma. Language: English read more
Tags: for
advanced
include
study
DSV and UTi Worldwide Combination Provides a Balanced Global Presence
2015-10-12 23:20:11| Logistics - Topix.net
The industry had just barely digested the XPO Logistics acquisition of Con-way when DSV announced its intentions to acquire UTi Worldwide. Perhaps not as surprising as XPO Logistics' recent acquisitions but it is one that can be a game changer within the global logistics market.
Tags: global
combination
presence
worldwide
Sites : [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] next »